Turkish Journal of Pathology

The Journal of Federation of Turkish Pathology Societies 

Open access

Turkish Journal of Pathology no longer publishes with De Gruyter Open

Why Submit

  • Language- revision services for non-native English speaking authors
  • Articles abstracted by online indexing services like National Library of
  • Medicine – MEDLINE/PUBMED and SCOPUS
  • Fast publishing time for research papers
  • On-line access through the journal website
  • Fast, blind peer reviews by international experts

Rejection Rate

  • 35%

CrossCheck Plagiarism Screening System

The editorial board is participating in a growing community of CrossCheck System's users in order to ensure that the content published is original and trustworthy. CrossCheck is a medium that allows for comprehensive manuscripts screening, aimed to eliminate plagiarism and provide a high standard and quality peer-review process.

Detailed description of the CrossCheck System can be found at:

Supplementary Materials

Abstracting & Indexing

Turkish Journal of Pathology is covered by the following services:

  • Baidu Scholar
  • Case
  • Chemical Abstracts Service (CAS) - CAplus
  • Chemical Abstracts Service (CAS) - SciFinder
  • CNKI Scholar (China National Knowledge Infrastructure)
  • CNPIEC - cnpLINKer
  • Dimensions
  • DOAJ (Directory of Open Access Journals)
  • EBSCO (relevant databases)
  • EBSCO Discovery Service
  • Genamics JournalSeek
  • Google Scholar
  • Index Copernicus
  • Japan Science and Technology Agency (JST)
  • J-Gate
  • JournalGuide
  • JournalTOCs
  • KESLI-NDSL (Korean National Discovery for Science Leaders)
  • Medline
  • Meta
  • Microsoft Academic
  • Naviga (Softweco)
  • NewJour - Electronic Journals & Newsletters
  • Primo Central (ExLibris)
  • Publons
  • PubMed
  • QOAM (Quality Open Access Market)
  • ReadCube
  • SCImago (SJR)
  • Sherpa/RoMEO
  • Summon (ProQuest)
  • TDNet
  • Ulrich's Periodicals Directory/ulrichsweb
  • WanFang Data
  • Web of Science - Emerging Sources Citation Index
  • WorldCat (OCLC)

Instructıons For Authors

Turkish Journal of Pathology (http://www.turkjpath.org) (ISSN: 1018-5615) is the official journal of the Federation of Turkish Pathology Societies. The journal is a peer-reviewed scientific journal published every four months, three times a year (January, May, September), and aims to reach all relevant national and international medical institutions and persons in printed and electronic versions free of charge. Articles in Turkish and English are welcomed. The journal does not have article processing charges (APCs) nor article submission charges.

Turkish Journal of Pathology is devoted to the continuing education of national and international practicing pathologists, and to provide a forum for social and scientific communication in the field. Studies that emphasize these aims provide the basis of publication, including original articles, case reports, reviews, abstracts from annual meetings, letters to editor, book reviews, and biographies. Turkish Journal of Pathology accepts only invited review articles.

A submitted article must be an original contribution not previously published (except as an abstract or a preliminary report), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in any languages. Articles presented at a meeting or symposium are accepted if this is stated.

Scientific Responsibility

Authors are responsible for their articles’ conformity to scientific rules. Each person listed as an author is expected to have participated in the study to a significant extent. The order of the authors’ names must be a joint decision. Authors must sign the author name order in the copyright transfer form. All authors’ names must be included under the article’s title. Any individual who does not meet the criteria for authorship but has contributed to the article can be listed in “Acknowledgement(s)” section.

Ethical Responsibility

Authors are responsible for their articles’ conformity to ethical rules. The study protocol for human experimentation must conform the ethical guidelines established in the World Medical Association Declaration of Helsinki. Therefore, all articles submitted for publication must specify that the ethic standards of the above committee were adhered. Any necessary permission documents from local and international ethic committees must also be sent with the article. Authors must specify in the method(s) section that they performed the study according to these principles and that they obtained “informed consent” from their institution’s ethic committees and the participants.

Articles reporting the results of experimental studies on animals must include a statement that study protocol was approved by the animal ethics committee of relevant institution and that the study was conducted in accordance with “Guide for the Care and Use of Laboratory Animals” (http://www.nap.edu/catalog/5140.html). Authors are strongly requested to send an approval of the relevant ethics committee.

If any previously published quoted passages, tables, figures, etc. are used in the article, authors should obtain written permission from publication rights holders, and should specify this in the article.

Authors must specify in the references page that they have no commercial relations or, if present, the nature of the relation (consultancy, other agreements) with commercial products or drugs used in their study or with any pharmaceutical companies or with companies providing financial sponsorship for the article.

The editors and publisher assume no responsibility regarding features and explanations of any commercial products advertised in the journal.

The confidentiality and privacy of patients and study participants:

Authors should avoid descriptive information such as patient names, initials, reference numbers or photographs to appear in their article. This information can be published if absolutely necessary for scientific reasons and only after obtaining written “informed consent” from the patient (or parents, or guardian). The article must also state that “informed consent” was obtained.

Relations with Editor(s), Author(s) and Referee(s)

Editors do not share information regarding articles (article receipt, review process, referee opinions or final results) with anyone except authors and referees. Referees and editorial board members cannot discuss articles in a public manner. Editors must send copies of the article to the editor once their review is complete. Referee reviews cannot be printed or disclosed without permission of the author and editor. Care is taken to keep the identities of the referees. In some cases, the editor may decide to send referee opinions on the article to other referees reviewing the same article to inform them during the process. All articles submitted will be subjected to peer-review by the editorial board, and the authors will be informed within 6 weeks. Editorial board reserves the right to make some revisions in the article. Revised articles should also be accompanied by a unique letter with responses to reviewers’ comments. Articles that do not comply with the journal requirements listed below may be returned without review at the discretion of the editors.


Articles should be typed in 12 pt (Times New Roman), double-spaced throughout with margins of 2.5 cm, and pages must be numbered on the right upper corner. Manuscripts must be in accordance with the International Committee of Medical Journal Editors: Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org/). Original articles should not exceed 15 double spaced typewritten pages, and case reports should not exceed 10 pages. Articles should be typewritten in either “doc” or “txt” format and organized as follows:

  • Title page: The title page should contain the article title, authors’ names and complete affiliations, a running title not exceeding 40 characters and the address for manuscript correspondence including e-mail address and telephone and fax numbers. If the article was presented at a scientific meeting, authors should provide a complete statement including date and place of the meeting.
  • Abstract and key words: Original articles should contain Turkish and English abstracts. For foreign authors, Turkish abstract and key words will be written by the editorial board. Abstracts must be no longer than 250 words. The structured abstract should include objective, materials and methods, results and conclusions in original articles. Case reports should also include a structured abstract [objective, case report(s), and conclusion]. Abbreviations should not be used in the abstract.

    The authors should list three to five key words or phrases taken from Index Medicus Medical Subject Headings (http://www.nlm.nih.gov/mesh/MBrowser.html).
  • Text: Original articles should be organized in four main headings: introduction, material and method, results, and discussion. Define abbreviations at first mention in the text and in each table and figure. If a brand name is cited, supply the manufacturer’s name and address (city and state/country). Case reports should include the following identifiable sections: introduction, case report(s), and discussion. An “acknowledgement(s)” section may be added following these sections to thank those who helped the study or preparation of the article, if any. The acknowledgements are placed at the end of the article, before the references. This section contains statements of gratitude for personal, technical or material help, etc.
  • References: References should be provided at the end of the article, under the title “References” and should be numbered and listed according to their order in the text. They should be referred to in parentheses within the text. Complete author citation is required (“et al” is not acceptable). The author(s) are responsible for the accuracy of the references. Journal titles should be abbreviated according to Index Medicus. Refer to the “List of Journals Indexed in Index Medicus” for abbreviations of journal names, or access the list at http://www.nlm.nih.gov/tsd/serials/lji.html.Abbreviations are not used for journals not in the Index Medicus. Only published articles or articles “in press” can be used in references. Authors must add the DOI and/or PMID numbers to the end of each citation. Example of references are given below:


    Hull ML, Escareno CR, Godsland JM, Doig JR, Johnson CM, Phillips SC, Smith SK, Tavaré S, Print CG, Charnock-Jones DS:
    Endometrial-peritoneal interactions during endometriotic lesion establishment.
    Am J Pathol 2008, 173:700-715 PMID: 18688027, DOI:10.2353/ajpath.2008.071128.


    Scheffler IE:
    Mitochondria. 2nd ed.,
    New Jersey, Wiley-Liss, 2008, 417-436

    Book chapters:

    Epstein JI: The Lower Urinary Tract and the Male Genital Tract. In Kumar V, Abbas A, Fausto N. (Eds):
    Robbins and Cotran Pathologic Basis of Disease. 7th ed.,
    Philadelphia, Elsevier Saunders, 2005, 1023-1058

    On-line articles:

    Abood S:
    Quality improvement initiative in nursing homes: the ANA acts in an advisory role.
    Am J Nurs [serial on the Internet]. 2002 Jun [cited 2002 Aug 12];102(6). Available from: http://www.nursingworld.org/AJN/2002/june/Wawatch.htm PMID: 12394070
  • Tables: Each table must be typed double-spaced on a separate page following the references. Tables should be numbered consecutively with Roman numerals in order of appearance in the text and should include a short descriptive title typed directly above and essential footnotes including definitions of abbreviations below. They should be self-explanatory and should supplement rather than duplicate the material in the text.
  • Figures: All figures should be numbered sequentially in the text with Arabic numbers and should be referred to in parentheses within the text. Art should be created/scanned and saved as either TIFF or JPEG format, submitted as a seperate file, and not embedded in the text file. Electronic photographs, radiographs, CT scans, and scanned images must have a resolution of at least 300 dpi and 1200x960 pixels. If not obligatory any text typewritten on the figures should be avoided.
  • Figure legends: Include legends for all figures. Legends should appear on a separate page after the tables, should be brief and specific, and should include magnification and the stain used. Abbreviations and symbols used in the figures must be denoted in the legend.


All manuscripts must be submitted on-line through the web site (http://www.turkjpath.org/submit). Corresponding author, should upload the “Turkish Journal of Pathology Author Responsibility and Copyright Transfer Form” with the main manuscript. Copyright transfer form can be downloaded from “http://www.turkjpath.org/copyright_transfer_form.doc


Authors will receive a complimentary electronic (PDF) reprint of the article and a printed version of the journal. No hardcopy complimentary reprints are provided by the publisher.


Copyright of an accepted article should be transferred to the Federation of Turkish Pathology Societies. This transfer covers the exclusive rights to reproduce and distribute the article.

Authors may make this published article available free on-line provided that the source of the published article is cited and the Federation of Turkish Pathology Societies is mentioned as copyright holder in such a case, a link to the original article in Turkish Journal of Pathology accompanied by the following statement should also be created: “The original article is available at http://www.turkjpath.org”. All articles published in this journal are protected by copyright. No material published in this journal may be reproduced in any forms without obtaining written permission from the Federation of Turkish Pathology Societies. The Federation of Turkish Pathology Societies does not accept any legal responsibility for errors, omissions or claims with respect to information published in the journal. The “Turkish Journal of Pathology Author Responsibility and Copyright Transfer Form”must be filled out and uploaded by the corresponding author with the main manuscript. If the form is not completed as instructed, the manuscript will not be considered for peer review. Each author should have participated sufficiently in the work, and the corresponding author should state this. Each field may include more than one author. The corresponding author accepts that all information included in the manuscript is complete and has been agreed on by all authors. Any conflict of interest obtained by financial or personal relationship and/or financial and material support should be reported by the corresponding author.

Editorial Correspondence

Dr.Ümit Çobanoğlu (Editor-in-Chief)
Karadeniz Technical University, School of Medicine,Department of Pathology
61080 Trabzon /TURKEY
Tel:+90 (462) 3775912 ; +90 (532) 3753860 
E-mail: drumitcoban@gmail.com

Publisher Correspondence

Can Kangal (Manager)
Buluş Design and Printing
Bahriye Üçok Caddesi No: 9/1, Beşevler,
06500, Ankara, Turkey
Tel : +90 (312) 223 55 44; +90 (312) 222 44 06
Fax : +90 (312) 222 44 07
E-mail: bulus@bulustasarim.com.tr

Ümit ÇOBANOĞLU, Karadeniz Technical University

Alp USUBÜTÜN, HacettepeUniversity
Fazilet KAYASELÇUK, Başkent University
Kutsal YÖRÜKOĞLU, Dokuz Eylül University

Associate Editors
Funda DEMİRAĞ, Atatürk Chest Dis. & Chest Surg. Hospital
Peyker DEMİRELİ, Celal Bayar University
Sergülen DERVİŞOĞLU, İstanbul University
Başak DOĞANAVŞARGİL, Ege University
Mine GÜLLÜOĞLU, İstanbul University
Aydın İŞİSAĞ, Celal Bayar University
Özgür METE, University of Toronto
Tolgay ÖCAL, Mayo Clinic
Önder ÖNGÜRÜ, Gülhane Military Medical Academy
Erdener ÖZER, Dokuz Eylül University
Aylar POYRAZ, Gazi University
Selda SEÇKİN, Bozok University
Banu SİS, University of Alberta
Aykut ÜREN,Georgetown University
Ekrem YAVUZ, İstanbul University

International Editorial Board
Volkan ADSAY, Emory University, United States
Sylvia L. ASA, Ontario Cancer Institute,Canada
Liliane BOCCON-GIBOD, Armand Trousseau Children’s Hospital, France
Nesimi BÜYÜKBABANİ, İstanbul University, Turkey
Eduardo CALONJE, St Thomas’ Hospital, United Kingdom
Fatima CARNEIRO, University of Porto, Portugal
Christopher P. CRUM, Harvard Medical School, United States
Beyhan DEMİRHAN, Başkent University, Turkey
Ahmet DOĞAN, Mayo Clinic, United States
Arzu ENSARİ, Ankara University, Turkey
Jonathan I. EPSTEIN, John’s Hopkins University, United States
Yener S. EROZAN, John’s Hopkins University, United States
Vincenzo EUSEBI, University of Bologna, Italy
Agnes FOGO, Vanderbilt University, United States
Andrew FOLPE, Mayo Clinic, United States
Maria Pia FOSCHINI, University of Bologna, Italy
David J. GRIGNON, Indiana University, United States
Ömer GÜNHAN, Gülhane Military Medical Academy, Turkey
Günter KLÖPPEL, Technical University of Munich, Germany
Işınsu KUZU, Ankara University, Turkey
Daniela MASSI, University of Florence, Italy
Şükrü Oğuz ÖZDAMAR, Bülent Ecevit University, Turkey
Anil Vasdev PARWANI, University of Pittsburgh, United States
Raymond W. REDLINE, Case Western Reserve University, United States
Miguel REYES-MÚGICA, Yale University, United States
Hemamali SAMARATUNGA, University of Queensland, Australia
Aydın Sav, Acıbadem University, Turkey
Fernando SCHMITT, University of Porto, Portugal
Hiroyuki SHIMADA, Childrens Hospital Los Angeles, United States
Manuel Sobrinho SIMÕES, University of Porto, Portugal
Figen SÖYLEMEZOĞLU, Hacettepe University, Turkey
Ayşegül Şahin, MD Anderson Cancer Center, United States
Henry TAZELAAR, Mayo Clinic, United States
Tarık TİHAN, University of California, United States
Toyonori TSUZUKI, Nagoya Daini Red Cross Hospital, Japan
İlhan TUNCER, Çukurova University, Turkey
Nükhet TÜZÜNER, İstanbul University, Turkey
Gordan M. VUJANIC, Cardiff University, United Kingdom
Suzan ZORLUDEMİR, Çukurova University, Turkey

Senior Consultant in Biostatistics
Ergun KARAAĞAOĞLU, HacettepeUniversity  

Consultants in Biostatistics

Dr. Aydın YULUĞ


Dr. Alp Usubütün (Editor-in-Chief)
Hacettepe University, School of Medicine, Department of Pathology,
06100 Sıhhiye, Ankara
Tel : +90 (312) 305 15 63; +90 (536) 514 77 17
E-mail: alpusubutun@yahoo.com


Can Kangal (Manager)
Buluş Design and Printing
Bahriye Üçok Caddesi No: 9/1 Beşevler,
06500, Ankara, Turkey
Tel : +90 (312) 223 55 44 ; +90 (312) 222 44 06
Fax : +90 (312) 222 44 07
E-mail: bulus@bulustasarim.com.tr

Bogumiła Zuga 32A Str.
01-811 Warsaw, Poland
T: +48 22 701 50 15

Journal Information
Impact Factor

Cite Score 2018: 0.88

SCImago Journal Rank (SJR) 2018: 0.3
Source Normalized Impact per Paper (SNIP) 2018: 0.577

Most Popular